Free Trial

NeuroBo Pharmaceuticals (NRBO) SEC Filings & 10K Form

→ weirdest stock market marches on (From DTI) (Ad)
Free NRBO Stock Alerts
$4.66
+0.06 (+1.30%)
(As of 05/17/2024 08:54 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media

Recent NeuroBo Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
05/09/2024
8:00 AM		NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
7:05 AM		NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2024
7:41 AM		NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form DEF 14A
04/30/2024
7:42 AM		NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form ARS
04/30/2024
7:30 AM		NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2024
11:15 PM		NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form EFFECT
04/17/2024
7:30 AM		NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
3:30 PM		NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
7:30 AM		NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
7:01 AM		NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
7:30 AM		NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
8:20 PM		NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Woodworth Marshall H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:30 AM		NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/29/2024
7:30 AM		NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
7:52 AM		NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/01/2024
7:30 AM		NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/18/2024
7:30 AM		NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2024
7:45 AM		NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
8:00 AM		NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2023
8:03 AM		NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2023
8:20 AM		NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2023
4:12 PM		NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Tursi James Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2023
7:20 AM		NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
3:39 PM		NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Tursi James Patrick (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/30/2023
3:31 PM		NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Woodworth Marshall H (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/30/2023
7:06 AM		NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/22/2023
7:03 AM		NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2023
3:15 PM		NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/15/2023
7:11 AM		NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/24/2023
3:15 PM		NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2023
7:18 AM		NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/03/2023
7:15 AM		NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/28/2023
5:02 AM		Kim Na Yeon (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Form 4/A
07/28/2023
5:08 AM		Kim Na Yeon (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/28/2023
5:11 AM		Glickman Mark A (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/28/2023
5:13 AM		GROVES JASON L (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/28/2023
5:15 AM		NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
STRICKLAND D GORDON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/28/2023
5:17 AM		NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Salsbury Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/28/2023
5:19 AM		KOVEN ANDREW I (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2023
7:36 AM		NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2023
7:26 AM		NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This Apple-like Innovator is Revolutionizing Healthcare (Ad)

AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.

Click here to learn more about the booming eHealth industry
06/13/2023
7:25 AM		NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies:
SEC Filings Tools:
This page (NASDAQ:NRBO) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Urgent Nvidia Warning
Altimetry
Shocking $16T Elon Musk Crypto Leak
Crypto 101 Media
He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”
InvestorPlace
Most important medical advance in 100 years
The Oxford Club
CEO of Biggest AI Chipmaker Just Dropped a Bombshell…
Banyan Hill Publishing
Missed NVDA? Buy this AI stock NOW
Chaikin Analytics
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
He Is Giving Away Bitcoin
Crypto Swap Profits